GGrantIndex
← Leaderboards

Nicholas K Foreman

University Of Colorado Denver

$4,734,103
Attributed
$4,734,103
Total exposure
3
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $711.4K · FY201024
$1M$750K$500K$250K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24

Funding mix

By agency

NIH$4,734,103 · 3

By mechanism

R01$4,734,103 · 3

Top collaborators

No co-investigators on record.

Most similar at University Of Colorado Denver

Same institution · by research overlap

Others in their field

Top investigators on “Childhood Brain Neoplasm

Research focus

Childhood Brain NeoplasmDesignOperative Surgical ProceduresTumorChildExcisionMolecularNeoplastic CellRecurrenceSamplingBrain NeoplasmsEpendymomaPhenotypeCessation Of LifeChildhood EpendymomaCellsBaseCancer EtiologyMalignant NeoplasmsAutomobile DrivingInsightMedulloblastomaIn VitroChemotherapy

Grant awards (14)

Epigenetic regulation of LDOC1 drives tumor biology in high risk ependymoma$337,922
R01 · FY2024 · CA · contact PI
Epigenetic regulation of LDOC1 drives tumor biology in high risk ependymoma$348,592
R01 · FY2023 · CA · contact PI
Investigation of a Novel Cancer Stem Cell Population in Ependymoma.$348,592
R01 · FY2023 · CA · contact PI
Investigation of a Novel Cancer Stem Cell Population in Ependymoma.$348,592
R01 · FY2022 · CA · contact PI
Epigenetic regulation of LDOC1 drives tumor biology in high risk ependymoma$348,592
R01 · FY2022 · CA · contact PI
Investigation of a Novel Cancer Stem Cell Population in Ependymoma.$355,706
R01 · FY2021 · CA · contact PI
Epigenetic regulation of LDOC1 drives tumor biology in high risk ependymoma$355,706
R01 · FY2021 · CA · contact PI
Investigation of a Novel Cancer Stem Cell Population in Ependymoma.$355,706
R01 · FY2020 · CA · contact PI
Epigenetic regulation of LDOC1 drives tumor biology in high risk ependymoma$355,706
R01 · FY2020 · CA · contact PI
Investigation of a Novel Cancer Stem Cell Population in Ependymoma.$355,706
R01 · FY2019 · CA · contact PI
Molecular and Cellular Characterization of Prognostic Immune Response in Childhoo$289,474
R01 · FY2013 · CA · contact PI
Molecular and Cellular Characterization of Prognostic Immune Response in Childhoo$307,951
R01 · FY2012 · CA · contact PI
Molecular and Cellular Characterization of Prognostic Immune Response in Childhoo$307,951
R01 · FY2011 · CA · contact PI
Molecular and Cellular Characterization of Prognostic Immune Response in Childhoo$317,907
R01 · FY2010 · CA · contact PI